Genpact Limited

As of June 30, 2026, Genpact Limited carries a market capitalization of 4.06B, placing it among publicly traded companies globally. Its enterprise value stands at 4.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Genpact Limited's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Genpact Limited has 168.03M shares outstanding.

As of June 30, 2026, Genpact Limited trades at a trailing price-to-earnings ratio of 8.11. The price-to-sales ratio is 0.90, and the price-to-book ratio stands at 1.78.

As of June 30, 2026, Genpact Limited trades at an EV/EBITDA multiple of 6.35 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.05 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 7.11 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Genpact Limited trades at an EV/FCF ratio of 9.08, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 4.84B versus a market cap of 4.06B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Genpact Limited maintains a current ratio of 2.00, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 54.31, indicating elevated leverage, while an interest coverage ratio of 10.98 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Genpact Limited posted a return on equity (ROE) of 22.45, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 14.51 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.87, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 15.81, useful for judging operating efficiency across full business cycles. The company generates approximately 31,719.51 in revenue per employee across its workforce of 144,875.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Genpact Limited recorded 157.91M in income tax expense. That works out to an effective tax rate of 23.64, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 667.91M, leaving 510.00M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Genpact Limited's stock has gained approximately 1.06% over the past 52 weeks. The 50-day moving average sits at 30.49, while the 200-day moving average is 31.21.

Over the twelve months ended June 30, 2026, Genpact Limited generated 4.60B in revenue and converted that into 510.00M in net income, yielding earnings per share of 2.94. EBITDA reached 763.49M, while operating income came in at 690.36M.

As of June 30, 2026, Genpact Limited holds 452.87M in cash and equivalents against 1.24B in total debt, resulting in a net debt position of 580.21M. Total book value stands at 2.28B, with working capital of 947.94M providing operational flexibility.

Genpact Limited produced 563.66M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -83.41M in capital expenditures, free cash flow totaled 480.25M - equivalent to 2.81 per share.

Over the twelve months ended June 30, 2026, Genpact Limited posted a gross margin of 36.46, reflecting its pricing power and cost economics. The operating margin of 15.02 and net profit margin of 11.10 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Genpact Limited paid dividends of 0.62 per share. The dividend payout ratio of 20.88 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 11.45, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 13.92, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Genpact Limited shareholders.

As of June 30, 2026, Genpact Limited has an Altman Z-Score of 4.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.